ZERO and Perthera Launch ‘Decode Your Prostate Cancer’ Program

ZERO and Perthera Launch ‘Decode Your Prostate Cancer’ Program
In collaboration with Perthera, a precision medicine intelligence company, the nonprofit group ZERO is launching "Decode Your Prostate Cancer," a program to give men fighting prostate cancer (PC) the ability to create personalized treatment plans. Each prostate cancer diagnosis is different due to its genetic form, and personalized medicine has been shown to offer an effective approach to treatment and post-treatment management. Through ZERO's partnership with Perthera, eligible patients with metastatic PC can access their molecular profiles for free and receive tailored plans of care based on which genetic mutations are driving their cancer. Perthera matches cancer patients with multiple therapeutic options, ranked by the highest probability of best outcome, through its “Perthera Report.” "One of the most significant recent breakthroughs in the fight against cancer is pinpointing the patient's tumor characteristics. The Perthera Report accomplishes this and more by providing ranked therapeutic options that have been reviewed by Perthera's experts and scientific tumor board," Jamie Bearse, president and CEO of ZERO, said in a press release. "With this critical data, we're able to put men battling prostate cancer on the best individualized treatment pathways, getting them back to life with their families," he said. A pilot program is currently taking place where patients are not only receiving treatment, they are also adding their anonymous data to the program’s database. This helps the
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *